Cargando…
Present and Future: Pharmacologic Treatment of Obesity
Obesity now presents one of the biggest health problems of our times. Diet and exercise are best for both prevention and treatment; unfortunately, both require much discipline and are difficult to maintain. Medications offer a possible adjunct, but their effect is modest, they are limited by side ef...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038640/ https://www.ncbi.nlm.nih.gov/pubmed/21331293 http://dx.doi.org/10.1155/2011/636181 |
_version_ | 1782198119153270784 |
---|---|
author | Glandt, Mariela Raz, Itamar |
author_facet | Glandt, Mariela Raz, Itamar |
author_sort | Glandt, Mariela |
collection | PubMed |
description | Obesity now presents one of the biggest health problems of our times. Diet and exercise are best for both prevention and treatment; unfortunately, both require much discipline and are difficult to maintain. Medications offer a possible adjunct, but their effect is modest, they are limited by side effects, and the weight loss lasts only as long as the drug is being taken, since as soon as treatment is stopped, the weight is regained. Sibutramine, a sympathomimetic medication which was available for long-term treatment, is the most recent of the drugs to be withdrawn from the market due to side effects; in this case it was an increased risk of cardiovascular events. This paper reviews those medications which are available for treatment of obesity, including many of those recently taken off the market. It also discusses some of the newer treatments that are currently being investigated. |
format | Text |
id | pubmed-3038640 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-30386402011-02-17 Present and Future: Pharmacologic Treatment of Obesity Glandt, Mariela Raz, Itamar J Obes Review Article Obesity now presents one of the biggest health problems of our times. Diet and exercise are best for both prevention and treatment; unfortunately, both require much discipline and are difficult to maintain. Medications offer a possible adjunct, but their effect is modest, they are limited by side effects, and the weight loss lasts only as long as the drug is being taken, since as soon as treatment is stopped, the weight is regained. Sibutramine, a sympathomimetic medication which was available for long-term treatment, is the most recent of the drugs to be withdrawn from the market due to side effects; in this case it was an increased risk of cardiovascular events. This paper reviews those medications which are available for treatment of obesity, including many of those recently taken off the market. It also discusses some of the newer treatments that are currently being investigated. Hindawi Publishing Corporation 2011 2011-02-08 /pmc/articles/PMC3038640/ /pubmed/21331293 http://dx.doi.org/10.1155/2011/636181 Text en Copyright © 2011 M. Glandt and I. Raz. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Glandt, Mariela Raz, Itamar Present and Future: Pharmacologic Treatment of Obesity |
title | Present and Future: Pharmacologic Treatment of Obesity |
title_full | Present and Future: Pharmacologic Treatment of Obesity |
title_fullStr | Present and Future: Pharmacologic Treatment of Obesity |
title_full_unstemmed | Present and Future: Pharmacologic Treatment of Obesity |
title_short | Present and Future: Pharmacologic Treatment of Obesity |
title_sort | present and future: pharmacologic treatment of obesity |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038640/ https://www.ncbi.nlm.nih.gov/pubmed/21331293 http://dx.doi.org/10.1155/2011/636181 |
work_keys_str_mv | AT glandtmariela presentandfuturepharmacologictreatmentofobesity AT razitamar presentandfuturepharmacologictreatmentofobesity |